Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2026-01-01 @ 1:42 AM
Study NCT ID:
NCT05939128
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-23
First Post:
2023-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-03
First Submit QC Date:
None
Study First Post Date:
2023-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED